GB1563284A - Production of mutant of aujeszky's virus - Google Patents

Production of mutant of aujeszky's virus Download PDF

Info

Publication number
GB1563284A
GB1563284A GB27522/77A GB2752277A GB1563284A GB 1563284 A GB1563284 A GB 1563284A GB 27522/77 A GB27522/77 A GB 27522/77A GB 2752277 A GB2752277 A GB 2752277A GB 1563284 A GB1563284 A GB 1563284A
Authority
GB
United Kingdom
Prior art keywords
virus
aujeszky
mutant
desoxyuridine
iodo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27522/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Publication of GB1563284A publication Critical patent/GB1563284A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB27522/77A 1976-07-02 1977-06-30 Production of mutant of aujeszky's virus Expired GB1563284A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG3365276 1976-07-02

Publications (1)

Publication Number Publication Date
GB1563284A true GB1563284A (en) 1980-03-26

Family

ID=3902412

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27522/77A Expired GB1563284A (en) 1976-07-02 1977-06-30 Production of mutant of aujeszky's virus

Country Status (7)

Country Link
AR (1) AR216081A1 (es)
BE (1) BE856351A (es)
CA (1) CA1069821A (es)
ES (1) ES460321A1 (es)
FR (1) FR2356726A1 (es)
GB (1) GB1563284A (es)
NL (1) NL7707341A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3122669A1 (de) * 1980-06-12 1982-02-11 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
HU187421B (en) * 1982-10-27 1986-01-28 Phylaxia Oltoanyagtermeloe Vallalat,Hu Process for producing inactivated, adjuvated serum against aujeszky's illness
US4514497B1 (en) * 1983-12-30 1998-02-24 Novagene Inc Modified live pseudorabies viruses

Also Published As

Publication number Publication date
ES460321A1 (es) 1978-11-01
FR2356726B1 (es) 1981-01-16
BE856351A (fr) 1977-10-31
FR2356726A1 (fr) 1978-01-27
CA1069821A (en) 1980-01-15
NL7707341A (nl) 1978-01-04
AR216081A1 (es) 1979-11-30

Similar Documents

Publication Publication Date Title
Yaffe Cellular aspects of muscle differentiation in vitro
Hauschka Cultivation of muscle tissue
US6303568B1 (en) Therapeutic antimicrobial polypeptides, their use and methods for preparation
Coleman et al. A clonal study of the reversible inhibition of muscle differentiation by the halogenated thymidine analog 5-bromodeoxyuridine
CN108823202A (zh) 用于特异性修复人hbb基因突变的碱基编辑系统、方法、试剂盒及其应用
Bonami et al. Rickettsial infection in marine crustacea
Gardner The use of tricine buffer in animal tissue cultures
Jeon et al. Temperature sensitivity: a cell character determined by obligate endosymbionts in amoebas
Müller et al. Morphogenetic factors in hydroids: I. Stolon tip activation and inhibition
Sonnenschein et al. Loss of growth hormone production following hybridization of a functional rat pituitary cell strain with a mouse fibroblast line
GB1563284A (en) Production of mutant of aujeszky's virus
JP4267689B2 (ja) 鳥類由来の細胞の培養方法および該培養方法によって得られた細胞系
KR20010033162A (ko) 생식세포로의 유전자 도입법
US3616203A (en) Virus culture and method
WO1982003408A1 (en) Method for the preparation of a dna-hybride,containing the complementary genome of the hepatitis a virus,the dna-hybride itself,the plasmic vector contain it,the specific proteins of the virus coded by the dna-hybride and vaccins containing them
Gibson et al. Extranuclear DNA and the endosymbionts of Paramecium aurelia
RU2085584C1 (ru) Способ получения рекомбинантных туляремийных микроорганизмов - продуцентов факторов вирулентности, рекомбинантный штамм francisella tularensis subspecies, holarctica r5s - продуцент фактора вирулентности francisella tularensis nearctica shu, рекомбинантный штамм francisella tularensis holarctica rn4 - продуцент фактора вирулентности pseudomonas pseudomallei c 141, рекомбинантный штамм francisella tularensis subspecies holarctica r1a - продуцент фактора вирулентности francisella tularensis nearctica b 399 a cole
CN114262687B (zh) 一种从非神经细胞转化制备保留年龄特征的人源性背根节神经元的方法
CN111793606B (zh) 一种提高CRISPR/Cas9介导的同源修复效率的方法
Amborski et al. Effect of peptides on animal cells in culture: I. Maintenance of beating heart cells
Shenoy Animal biotechnology
Klebe Genetic mapping of a human regulator gene
SU872547A1 (ru) Способ культивировани клеток
Hilwig et al. Characterization of insect cell lines by DNA content 1, 2
DiZerega et al. The effect of nerve growth factor on dispersed neuronal-HeLa heterokaryons

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee